Revvity, Inc. (RVTY) compared with its closest peers (A, WAT, ILMN, MTD, TRMB): P/E 77.0 vs industry 51.8. Peer set by Business model: Medical Devices / Life Science Tools; 10 closest by market cap; US-domiciled. First-party data.
| Company | Market Cap | P/E |
|---|---|---|
| Agilent Technologies, Inc. (A) | $44.17B | 31.2 |
| Waters Corporation (WAT) | $39.76B | 239.3 |
| Illumina, Inc. (ILMN) | $32.21B | 51.5 |
| Mettler-Toledo International Inc. (MTD) | $30.21B | 38.3 |
| Trimble Inc. (TRMB) | $13.91B | 44.5 |
| Bio-Rad Laboratories, Inc. (BIO) | $10.15B | 10.9 |
| Avantor, Inc. (AVTR) | $9.73B | -14.7 |
| Bruker Corporation (BRKR) | $9.13B | -314.1 |
| 10x Genomics, Inc. (TXG) | $8.16B | -46.6 |
| Alamar Biosciences, Inc. (ALMR) | $2.40B | — |
| Stock P/E | 77.0 |
| Sector P/E (Technology) | 33.9 |
| Industry P/E (Measuring & Control Equipment) | 51.8 |
| vs Sector | 126.9% |
| vs Industry | 48.5% |
RVTY overview · RVTY earnings · RVTY financials · RVTY KPIs · RVTY investor relations · RVTY ownership · RVTY filings
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.